Document is current
Any future updates will be listed below
-
Authors
Herder, Christian https://orcid.org/0000-0002-2050-093X
Zhu, Anna
Schmitt, Andreas
Spagnuolo, Maria C.
Kulzer, Bernhard
Roden, Michael https://orcid.org/0000-0001-8200-6382
Hermanns, Norbert
Ehrmann, Dominic
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (HE 4510/9-1, HE 3053/4-1, EH 538/3-1)
Bundesministerium für Gesundheit (n/a, n/a)
Bundesministerium für Bildung und Forschung (n/a, n/a, FKZ 01GI089, FKZ 01GI1105)
Ministry of Culture and Science of the state North Rhine-Westphalia (Düsseldorf, Germany); German Center for Diabetes Research
- License Information
-
More Information
Article History
Received: 23 April 2024
Revised: 6 December 2024
Accepted: 13 December 2024
First Online: 11 January 2025
Competing interests
: MR received lecture fees or served on advisory boards for AstraZeneca, Boehringer-Ingelheim, Echosens, Eli Lilly, Madrigal, MSD Sharp & Dohme, Novo Nordisk and Target RWE and performed investigator-initiated research with support from Boehringer-Ingelheim, Novo Nordisk and Nutricia/Danone to the German Diabetes Center (DDZ). NH reports advisory board member fees from Abbott Diabetes Care, Roche Diabetes Care and Insulet as well as honoraria for lectures from Berlin Chemie AG, Becton Dickenson, Sanofi Germany, Roche Diabetes Care and Dexcom Germany. DE reports advisory board member fees from Dexcom Germany and Roche Diabetes Care as well as honoraria for lectures from Berlin Chemie AG, Dexcom Germany, Sanofi-Aventis Germany and Roche Diabetes Care. All other authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.
